Through analyses of brain specimens, EMMPRIN has since been found to be associated with many diseased conditions of the CNS, including gliomas [20], Alzheimer’s disease [21], stroke/ischemia [22], and MS [8, 9]. This evidence concerns the gene BSG and early-onset autosomal dominant Alzheimer disease.